• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Health Tip: Drinking and Boating Don't Mix

drugsJune 13, 2019

Tag: Drinking , boating , alcohol , Driving

In most states, laws for drinking and boating are similar to those governing drinking and driving.

Boating laws apply to most any boat, including canoes, kayaks and rowboats. Alcohol is the top contributor to boating accidents, says the American Addiction Centers.

Drinking and boating increase your chances of drowning, falling off the boat and driving recklessly.

There is no safe amount of alcohol for a boat operator, the addiction group says.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com

Previous:Which Foods Are the Best Sources of Dietary Fiber?

Next:Weight Loss Surgery May Not Relieve Acid Reflux

Related News

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Pr

PRNewswireDecember 18, 2024

Ascletis Pharma Inc. announces encouraging efficacy results from its study in diet-induced obese (DIO) mice combining ASC47, a first-in-class muscle-preserving weight loss drug candidate for the treatment of obesity.

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PRNewswireDecember 19, 2024

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

Health Tip: Drinking and Boating Don't Mix | Pharmasources.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

PeproMene Bio, Inc.has announced an $11M investment from the Institute for Follicular Lymphoma Innovation (IFLI) to support the clinical development of PMB-CT01 (BAFF-R CAR T cell therapy) in patients with relapsed or refractory (r/r) follicular lymphoma.

You may like
More>>

3,5-Dichlorobenzyl alcohol

3,5-Dichlorobenzyl alcohol
Isopropyl Alcohol67-63-0

Isopropyl Alcohol67-63-0
Benzyl Alcohol (for injection)

Benzyl Alcohol (for injection)
tetrahydrofurfuryl alcohol(97-99-4)

tetrahydrofurfuryl alcohol(97-99-4)
4-Methoxyphenethyl alcohol

4-Methoxyphenethyl alcohol
4-methyl-2,3,5,6-tetrafluorobenzyl alcohol

4-methyl-2,3,5,6-tetrafluorobenzyl alcohol
Propargyl-PEG3-alcohol

Propargyl-PEG3-alcohol
4-Bromo-3,5-dimethoxybenzyl alcohol

4-Bromo-3,5-dimethoxybenzyl alcohol
2,4,5-Trifluorobenzylalcohol

2,4,5-Trifluorobenzylalcohol
N-Boc-PEG12-alcohol

N-Boc-PEG12-alcohol

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service